India plans to revamp pharmaceutical storage regulations for vaccines and biological products. The government will classify medications into thermostable and thermolabile categories to prevent improper temperature storage. The Central Drugs Standard Control Organisation identified 203 formulations requiring strict temperature checks. A sub-committee recommended revising storage rules under the Drugs and Cosmetics Act to ensure uniform standards across India's $12 billion biopharmaceutical market.